[Profound survival benefit with concurrent chemotherapy: insights from a Chinese phase III trial in older patients with esophageal cancer].

Subjects

Subjects :

Aged
Chemoradiotherapy
China
Humans
Esophageal Neoplasms drug therapy

Details

Language :

German

ISSN :

1439-099X

Volume :

198

Issue :

5

Database :

MEDLINE

Journal :

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Publication Type :

Academic Journal

Accession number :

35286400

Full Text :

https://doi.org/10.1007/s00066-022-01921-6